AAV Production in Culture Biosciences’ 250mL Bioreactors

News
Article

Sponsored Content

Adeno-associated virus (AAV) is a critical vector in gene therapy, but process robustness and scalability can pose challenges. This whitepaper demonstrates how Culture Biosciences' on-demand fleets of 250mL bioreactors enable large-scale experimentation and real-time data access to optimize upstream processes. Learn how process optimization can increase the fraction of full AAV capsids, accelerating your path to market.

Related Content
© 2024 MJH Life Sciences

All rights reserved.